These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


178 related items for PubMed ID: 36463144

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Vildagliptin ameliorates intrapulmonary vasodilatation and angiogenesis in chronic common bile duct ligation-induced hepatopulmonary syndrome in rat.
    Mangoura SA, Ahmed MA, Hamad N, Zaka AZ, Khalaf KA, Mahdy MA.
    Clin Res Hepatol Gastroenterol; 2024 Aug; 48(7):102408. PubMed ID: 38925324
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Analysis of pulmonary heme oxygenase-1 and nitric oxide synthase alterations in experimental hepatopulmonary syndrome.
    Zhang J, Ling Y, Luo B, Tang L, Ryter SW, Stockard CR, Grizzle WE, Fallon MB.
    Gastroenterology; 2003 Nov; 125(5):1441-51. PubMed ID: 14598260
    [Abstract] [Full Text] [Related]

  • 9. Quercetin administration ameliorates pulmonary complications of cirrhosis in rats.
    Tieppo J, Cuevas MJ, Vercelino R, Tuñón MJ, Marroni NP, González-Gallego J.
    J Nutr; 2009 Jul; 139(7):1339-46. PubMed ID: 19494027
    [Abstract] [Full Text] [Related]

  • 10. Does Biliodigestive Anastomosis Have Any Effect on the Reversal of Hepatopulmonary Syndrome in a Biliary Cirrhosis Experimental Model?
    Corbi LE, Tannuri ACA, de Aro Braz MJ, Paes VR, Sbragia L, Figueira RL, da Costa KM, Coelho MCM, Gonçalves JO, Serafini S, Tannuri U.
    Dig Dis Sci; 2019 Nov; 64(11):3192-3202. PubMed ID: 31076984
    [Abstract] [Full Text] [Related]

  • 11. Increased pulmonary vascular endothelin B receptor expression and responsiveness to endothelin-1 in cirrhotic and portal hypertensive rats: a potential mechanism in experimental hepatopulmonary syndrome.
    Luo B, Liu L, Tang L, Zhang J, Stockard CR, Grizzle WE, Fallon MB.
    J Hepatol; 2003 May; 38(5):556-63. PubMed ID: 12713865
    [Abstract] [Full Text] [Related]

  • 12. Attenuation of experimental hepatopulmonary syndrome in endothelin B receptor-deficient rats.
    Zhang J, Ling Y, Tang L, Luo B, Pollock DM, Fallon MB.
    Am J Physiol Gastrointest Liver Physiol; 2009 Apr; 296(4):G704-8. PubMed ID: 19196949
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cholangiocyte endothelin 1 and transforming growth factor beta1 production in rat experimental hepatopulmonary syndrome.
    Luo B, Tang L, Wang Z, Zhang J, Ling Y, Feng W, Sun JZ, Stockard CR, Frost AR, Chen YF, Grizzle WE, Fallon MB.
    Gastroenterology; 2005 Aug; 129(2):682-95. PubMed ID: 16083721
    [Abstract] [Full Text] [Related]

  • 16. Surfactant protein A is decreased in the lung of rats with hepatopulmonary syndrome.
    Nacif LS, Andraus W, Kubrusly MS, Kubrusly FS, Gebara VC, Ishizawa A, D'Albuquerque LA.
    Acta Cir Bras; 2014 Sep; 29(9):573-8. PubMed ID: 25252203
    [Abstract] [Full Text] [Related]

  • 17. The role of receptor tyrosine kinase activation in cholangiocytes and pulmonary vascular endothelium in experimental hepatopulmonary syndrome.
    Yang W, Zhang J, Hu B, Wu W, Venter J, Alpini G, Fallon MB.
    Am J Physiol Gastrointest Liver Physiol; 2014 Jan 01; 306(1):G72-80. PubMed ID: 24200956
    [Abstract] [Full Text] [Related]

  • 18. Effect of Atorvastatin, Curcumin, and Quercetin on miR-21 and miR-122 and their correlation with TGFβ1 expression in experimental liver fibrosis.
    Nozari E, Moradi A, Samadi M.
    Life Sci; 2020 Oct 15; 259():118293. PubMed ID: 32822714
    [Abstract] [Full Text] [Related]

  • 19. N-acetylcysteine effects on genotoxic and oxidative stress parameters in cirrhotic rats with hepatopulmonary syndrome.
    Vercelino R, Tieppo J, Dias AS, Marroni CA, Garcia E, Meurer L, Picada JN, Marroni NP.
    Basic Clin Pharmacol Toxicol; 2008 Apr 15; 102(4):370-6. PubMed ID: 18341514
    [Abstract] [Full Text] [Related]

  • 20. Pentoxifylline attenuation of experimental hepatopulmonary syndrome.
    Zhang J, Ling Y, Tang L, Luo B, Chacko BK, Patel RP, Fallon MB.
    J Appl Physiol (1985); 2007 Mar 15; 102(3):949-55. PubMed ID: 17110505
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.